|
NMH: Posted on Friday, September 30, 2011 12:56 PM
Do you have questions about treatment options, family history, support services and fertility after cancer?
This free, interactive discussion about breakthroughs in breast cancer is your opportunity to have your questions answered by experts from the Lurie Cancer Center, visit exhibits, and learn about local and national support services!
Sunday, October 2, 2011
1 p.m. – 4 p.m. (Exhibits open at noon)
Arthur Rubloff Building, Thorne Auditorium
375 E. Chicago Ave., Chicago
(Corner of Chicago Ave. |
|
|
NMH: Posted on Friday, September 30, 2011 12:31 PM
A one-day interactive course for women living with ovarian cancer--past or present--or those at increased risk of developing the disease along with their families and caregivers. The course will provide current information, valuable resources, access to experts in the field, and an opportunity to connect with others in the ovarian cancer community in a warm and supportive environment.
Free Admission
Saturday, October 1, 2011
8:30 a.m. — 4:00 p.m.
Robert H. Lurie Medical Research Center - Hughes Auditorium |
|
|
NWAOKAI-BEECHAM: Posted on Thursday, September 29, 2011 11:04 PM
Get ready to encourage awareness of breast cancer in the month of October. October is Breast Cancer Awareness Month. Encourage the women you know to get a mammogram for early cancer detection if they are at least 35 years of age. Many doctors recommend starting your mammograms by age 45, but younger women are getting cancer. Therefore, do your self-breast exams. look for any lumps out of the ordinary. If you suspect an unknown lump, swelling, or nipple discharge get a mammogram as soon as possible. |
|
|
NCI: Posted on Monday, September 26, 2011 8:36 PM
Researchers have found that H. pylori infection triggers breaks in both strands of the DNA double helix in the nucleus of gastricepithelial cells. These DNA double-strand breaks activate the cells’ machinery for repairing DNA damage, but prolonged H. pylori infection overloads this machinery, which could lead to mutations involved in gastric cancer |
|
|
NCI/ Nwaokai-Beecham: Posted on Thursday, September 22, 2011 4:42 PM
Phase III clinical trials are the "gold standard" in oncology research, providing the highest level of evidence to support the effectiveness of cancer treatments. These trials usually involve hundreds of patients at multiple sites, cost millions of dollars, and take years to complete. Most important, the published results of a phase III trial can substantially change the standard of care for a particular tumor type or stage of disease. The American Society of Clinical Oncology (ASCO) annual meeting, the largest meeting of its kind for oncologists, often provides a "first look" at potentially practice-changing clinical trial results, which are subsequently fleshed out in reports published in peer-reviewed journals. |
|
|
NCI: Posted on Wednesday, September 21, 2011 5:02 PM
Name of the TrialNatural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) (NCI-10-C-0096). See the protocol summary.
Principal Investigator
Dr. Ola Landgren, NCI Center for Cancer Research
Why This Trial Is ImportantMultiple myeloma is a rare type of cancer in which abnormal plasma, or myeloma, cells collect in the bone marrow and other soft tissue. These abnormal cells can form tumors that damage bone directly. They also produce large amounts of antibodies, known as |
|
|
NCI: Posted on Tuesday, September 20, 2011 11:28 PM
In a proof-of-concept study, a fluorescent probe designed to bind deposits of cancer in the abdominal cavity during surgery, thus helping the surgeon remove the cells. The target of the probe, called folate receptor-alpha, is found in 90 to 95 percent of ovarian cancers but not in normal tissue. The study, the first in of its kind in humans, was led by Dr. Gooitzen M. van Dam of the University of Groningen in the Netherlands and published online |
|
|
NCI: Posted on Tuesday, September 20, 2011 8:53 PM
studies. Young age at diagnosis is thought to be a risk factor for disease recurrence, and many young women with breast cancer choose mastectomy for treatment. The research was presented at the |
|
|
NCI: Posted on Tuesday, September 20, 2011 8:36 PM
Mutations in the BRCA1 gene are known to increase a woman’s lifetime risk of developing breast and ovarian cancers, but researchers are still investigating how the protein encoded by this gene helps suppress the formation of tumors. A study by Dr. Inder Verma and his colleagues at the Salk Institute for Biological Studies in the September 8 Nature offers some clues.Using mice and human breast cancer cells, the researchers identified a series of |
|
|
Pancreatic Cancer Center: Posted on Monday, September 19, 2011 6:56 PM
Research
A record total of more than
$3.1 million in research funding will be awarded in 2012. We are now accepting grant applications.
Create a Lasting Tribute
We now offer Named Legacy Funds which present a very special and lasting way to pay tribute to someone you cherish.
Greet Fall in
Purple Style
Add to your awareness collection with the latest designs and fashions at Shop Purple.
Keep the
Memory Alive
Create a tribute page for your loved one and help everyone affected by pancreatic cancer. |
|
